Browsing: Lymphoma

Top Line: Can response adapted radiation for orbital lymphoma maintain local control while sparing some patients from full dose treatment?The…

Top Line: Does comprehensive bridging radiation improve outcomes for patients receiving CART for relapsed/refractory B-cell lymphoma?The Study: Failure at pre-existing…

Top Line: Does consolidative radiation improve survival for younger patients with aggressive B-cell lymphoma?The Study: R-MegaCHOEP was a randomized trial…

Top Line: Does the omission of radiation for favorable Hodgkin lymphoma reduce late events while maintaining non-inferior disease outcomes? The…

A small single-arm trial of patients with low-risk (no B symptoms or extranodal disease and limited sites of recurrence), relapsed,…

Extranodal marginal zone lymphoma of bronchus associated lymphoid tissue (BALT) is rare and generally has an excellent prognosis with resection…

Top Line: Can PET adaptive therapy be used for nodular lymphocyte predominant Hodgkin lymphoma?The Study: Nodular lymphocyte predominant Hodgkin lymphoma…

Top Line: Is it safe to omit consolidative radiation in patients with primary mediastinal b-cell lymphoma who have a complete…

ZUMA-7 trial reported a significant advantage in overall survival with the delivery of salvage anti-CD19 CAR T-cell Yescarta for relapsed…

The CD30 antibody-drug conjugate brentuximab vedotin is newly approved for use in classical Hodgkin lymphoma as well as mycosis fungoides,…